Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
35.94 USD | +0.69% | -1.23% | -6.73% |
03:44pm | Baxter International's Clinolipid Injection Approved for Expanded Use in US | MT |
May. 10 | TD Cowen Downgrades Baxter International to Hold From Buy, Price Target is $40 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.73% | 18.19B | |
-4.36% | 182B | |
+1.69% | 110B | |
-2.35% | 68.11B | |
+2.63% | 50.53B | |
+9.69% | 44.8B | |
+2.84% | 40.7B | |
+21.84% | 32.25B | |
+3.50% | 26.53B | |
+15.25% | 25.02B |
- Stock Market
- Equities
- BAX Stock
- News Baxter International Inc.
- Keybanc Adjusts Price Target on Baxter International to $53 From $52, Keeps Overweight Rating